INTRODUCTION
Gene therapy is being develo~ed to treat a variety of different human diseases including autoimmune md vascular diseases as well as cancer. High levels of gene expression, as well as temporal control and regulation d gene expression are needed for effective clinical gene therapy. Better delivery vectors, which enable site-specific gene delivery, are also needed.
MATERIALS AND METHODS
In vitro experiments were performed in five different mammalian cell culture lines: HeLa, NIH/3T3, COS-1, C-127i, and N-MuLi. A 1.O-MHZ, continuous-wave Rich-Mar Model No 25 therapeutic ultrasound transducer (Rich-Mar, Inola, OK) was used to insonate cells and tissues for in vivo experiments. Cell survival was assessed in cell culture by MTT assay.z Transection was performed using various commercially available cationic liposomes using plasmid genes p-chloramphenicol acetyl transferase (p-CA~, beta galactosidase (B-gal), and green fluorescent protein (GFP). Acoustically active cationic liposomes were prepared by formulating the cationic lipids with pefluorohexane as well as other fluoroctin materials. Transection expertients were performed in cell culture with these acoustically active liposomes and in vivo, in fish and mice, followhtg intramuscular and intravenous injection. To assess effects of cell permeability caused by ultrasound, cells were exposed to FITCIabeled dextran tier ultrasound. Reverse transcriptase-polyrnerase chain reaction (RT-PCR) was used to assess m-RNA levels of a variety of cell repair genes before and afier ultrasound exposure in NIH/3T3 cells.
RESULTS
Ultrasound enhanced gene expression from transection in all five cell lines; the increase was most marked in the NIH/3T3 cells, which only had very low levels of expression before ultrasound (Figure 1 ). The level of ultrasound energy required to enhance gene expression was insufficient to cause an appreciable rise in temperature or a decrease in cell survival. Ultrasound increased cell permeability to macromolecules and hcreased expression of cell repair genes. The acoustically active fluorocarbon gene carriers were more effwtive than the conventional cationic liposomes in increasing gene expression following transection with or without ultrasound. Ultrasound enhanced gene expression in fish and mice following intramuscular and intravenous injection with both conventional and acoustically active gene carriers. Following W gene administration, preferential gene expression was seen in the tissue of insolation.
CONCLUSION
Ultrasound enhances gene expression from transection. The mechanisms underlying this phenomenon likely include increased cell permeability facilitating better delivery, but even more important, gene activation. Ultrasound-enhanced gene activation may involve increased translation and gene integration. Ultrasound may be used as an "on" switch to control gene expression following tiarssfection. Efficient new gene delivery vectors have been developed that provide site-specific gene delivery within the field of ultrasound insolation @igure 2), Ultrasound holds great promise for improving eficacy and control of delivery in gene therapy.
